Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer

被引:0
|
作者
Yoh Watanabe
Tomomaro Etoh
Eiji Koike
Yoshiaki Mizuno
Wei-Min Wang
Hiroshi Hoshiai
机构
[1] Kinki University School of Medicine,Department of Obstetrics and Gynecology
关键词
Recurrent ovarian cancer; Salvage therapy; Cyclophosphamide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:468 / 471
页数:3
相关论文
共 50 条
  • [1] Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer
    Watanabe, Yoh
    Etoh, Tomomaro
    Koike, Eiji
    Mizuno, Yoshiaki
    Wang, Wei-Min
    Hoshiai, Hiroshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (05) : 468 - 471
  • [2] CLINICAL BENEFIT OF ORAL METRONOMIC CYCLOPHOSPHAMIDE ADMINISTRATION IN HEAVILY PRETREATED RECURRENT EPITHELIAL OVARIAN CANCER
    Attianese, D.
    Badellino, E.
    Villa, M.
    Bellero, M.
    Massobrio, R.
    Fuso, L.
    Biglia, N.
    Ferrero, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A230 - A230
  • [3] Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
    Ferrandina, Gabriella
    Corrado, Giacomo
    Mascilini, Floriana
    Malaguti, Paola
    Samaritani, Riccardo
    Distefano, Mariagrazia
    Masciullo, Valeria
    Di Legge, Alessia
    Savarese, Antonella
    Scambia, Giovanni
    BMC CANCER, 2014, 14
  • [4] Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
    Gabriella Ferrandina
    Giacomo Corrado
    Floriana Mascilini
    Paola Malaguti
    Riccardo Samaritani
    Mariagrazia Distefano
    Valeria Masciullo
    Alessia Di Legge
    Antonella Savarese
    Giovanni Scambia
    BMC Cancer, 14
  • [5] Salvage therapy with topotecan in heavily pretreated ovarian cancer patients
    Bodnar, Lubomir
    Wcislo, Gabriel
    Nasilowska, Anna
    Szarlej-Wcislo, Katarzyna
    Gasowska-Bodnar, Agnieszka
    Smoter, Marta
    Szczylik, Cezary
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (06) : 815 - 821
  • [6] Salvage therapy with topotecan in heavily pretreated ovarian cancer patients
    Lubomir Bodnar
    Gabriel Wcislo
    Anna Nasilowska
    Katarzyna Szarlej-Wcislo
    Agnieszka Gasowska-Bodnar
    Marta Smoter
    Cezary Szczylik
    Journal of Cancer Research and Clinical Oncology, 2009, 135
  • [7] Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer
    Chura, Justin C.
    Van Iseghem, Kelin
    Downs, Levi S., Jr.
    Carson, Linda F.
    Judson, Patricia L.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 326 - 330
  • [8] METRONOMIC ORAL CYCLOPHOSPHAMIDE IN THE SALVAGE TREATMENT OF HEAVILY TREATED OVARIAN CANCER PATIENTS: A RETROSPECTIVE, MULTICENTER STUDY
    Corrado, G.
    Mascilini, F.
    Savarese, A.
    Samaritani, R.
    Salutari, V.
    Di Stefano, M.
    Malaguti, P.
    Vizza, E.
    Scambia, G.
    Ferrandina, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [9] Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer
    Sanchez-Munoz, Alfonso
    Mendiola, Cesar
    Perez-Ruiz, Elisabeth
    Rodriguez-Sanchez, Cesar A.
    Miguel Jurado, Jose
    Alonso-Carrion, Lorenzo
    Ghanem, Ismael
    de Velasco, Guillermo
    Quero-Blanco, Cristina
    Alba, Emilio
    ONCOLOGY, 2010, 79 (1-2) : 98 - 104
  • [10] Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer
    Petrioli, Roberto
    Roviello, Giandomenico
    Fiaschi, Anna Ida
    Laera, Letizia
    Miano, Salvatora Tindara
    Marrelli, Daniele
    Roviello, Franco
    Bianco, Vincenzo
    Francini, Edoardo
    FUTURE ONCOLOGY, 2015, 11 (18) : 2563 - 2574